Translations on this website are prepared by a third-party provider. Some portions may be incorrect. Some items—including downloadable files or images—cannot be translated at all. No liability is assumed by Beth Israel Deaconess Medical Center for any errors or omissions. Any user who relies on translated content does so at his/her own risk.
The HMS Initiative for RNA Medicine brings together leading investigators in the field to pursue new lines of inquiry into non-coding RNA. View the Initiative’s series of virtual seminar presentations and other videos below.
"Targeting telomerase RNA in degenerative diseases" Suneet Agarwal, MD, PhD Assistant Professor of Pediatrics, Harvard Medical School
Co-Program Leader for the Stem Cell Transplant Center
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Given November 18, 2020
"A small RNA based innate immune system" Gregory J. Hannon, PhD, FRS, FMedSci, FAACR Royal Society Wolfson Research Professor
Director, CRUK Cambridge Institute, University of Cambridge
Given September 15, 2020
RNA Technology Showcase: Somagenics and RealSeq Bioscience
“Prospects for hyper-individualized RNA medicines” Tim Yu, MD, PhD
Attending Physician & Researcher, Division of Genetics and Genomics, Boston Children’s Hospital
Assistant Professor, Harvard Medical School
Associate Member, Broad Institute
Given July 29, 2020
The Institute for RNA Medicine at the BIDMC Cancer Center is making and translating RNA discoveries into novel therapeutics and diagnostics through the work of world-class scientists.
Beth Israel Deaconess Medical Center Pathologist Andrew Beck, MD, has developed C-Path, short for Computational Pathologist, a computer algorithm that yields highly detailed and accurate information about cancerous tissue.